228 related articles for article (PubMed ID: 9874450)
61. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.
Cottone M; Turri M; Caltagirone M; Maringhini A; Sciarrino E; Virdone R; Fusco G; Orlando A; Marino L; Pagliaro L
Hepatogastroenterology; 1988 Jun; 35(3):101-3. PubMed ID: 2456973
[TBL] [Abstract][Full Text] [Related]
62. [Is the focal echographic lesion of the liver in patients with cirrhosis always correlated with hepatocellular carcinoma? 217 cases].
Buffet C; Prades P; Hagege H; Cauquil P; Ink O; Etienne JP
Presse Med; 1988 Sep; 17(32):1629-32. PubMed ID: 2460850
[TBL] [Abstract][Full Text] [Related]
63. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
[TBL] [Abstract][Full Text] [Related]
64. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
65. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Giannini EG; Farinati F; Trevisani F
Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
[No Abstract] [Full Text] [Related]
66. Changes in serum alpha fetoprotein in patients with recurrent hepatocellular carcinoma following hepatectomy.
Liu G; Wang K; Li J; Xia Y; Lu L; Wan X; Yan Z; Shi L; Lau WY; Wu M; Shen F
J Gastroenterol Hepatol; 2015 Sep; 30(9):1405-11. PubMed ID: 25801981
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
El-Sherif WT; Makhlouf NA; El-Gendi SS; Hassan HI; Herdan OM
Egypt J Immunol; 2012; 19(2):53-65. PubMed ID: 23885407
[TBL] [Abstract][Full Text] [Related]
68. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
[TBL] [Abstract][Full Text] [Related]
69. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
70. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.
Pateron D; Ganne N; Trinchet JC; Aurousseau MH; Mal F; Meicler C; Coderc E; Reboullet P; Beaugrand M
J Hepatol; 1994 Jan; 20(1):65-71. PubMed ID: 7515408
[TBL] [Abstract][Full Text] [Related]
71. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
[TBL] [Abstract][Full Text] [Related]
72. [Prospective study on the diagnosis of hepatocellular carcinoma by using alpha-fetoprotein reactive to lentil lectin].
Tu Z
Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):138-40, 189. PubMed ID: 1377590
[TBL] [Abstract][Full Text] [Related]
73. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.
Sarasin FP; Giostra E; Hadengue A
Am J Med; 1996 Oct; 101(4):422-34. PubMed ID: 8873514
[TBL] [Abstract][Full Text] [Related]
74. [Decarboxyprothrombin: importance in the diagnosis of hepatocellular carcinoma].
Bon C; Brillard B; Gelineau MC; Mailliavin A; Trépo C; Pichot J
Ann Biol Clin (Paris); 1998; 56(2):175-81. PubMed ID: 9754243
[TBL] [Abstract][Full Text] [Related]
75. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
76. [Variable clinical symptoms of hepatocellular carcinoma].
Struve C; Heusermann U
Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
[TBL] [Abstract][Full Text] [Related]
77. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
78. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
79. Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions.
Khalil A; Elgedawy J; Faramawi MF; Elfert A; Salama I; Abbass A; Elsaid H; Elsebaai H
Tumori; 2013; 99(1):100-7. PubMed ID: 23549008
[TBL] [Abstract][Full Text] [Related]
80. Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma.
Amuro Y; Nakaoka H; Shimomura S; Fujikura M; Yamamoto T; Tamura S; Hada T; Higashino K
Clin Chim Acta; 1988 Dec; 178(2):151-8. PubMed ID: 2854011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]